From the CMS doc “Medicare Drug Value Negotiation Program: Chosen Medication for Preliminary Value
Applicability Yr 2027“:
On January 17, 2025, CMS introduced the number of the beneath record of 15 medicine coated below Medicare Half D for the second cycle of negotiations (preliminary worth applicability 12 months 2027), primarily based on complete gross coated prescription drug prices below Medicare Half D and different standards as required by the regulation.
With the Trump inauguration to happen on Monday, will the Medicare Drug Value Negotiation course of change with the brand new administration? Anna Kaltenboeck notes in EndPoints Information:
…the subsequent administration won’t have “blanket authority to vary the core elements of the regulation,” sure points of the method could be modified with out legislative motion.
For instance, CMS might alter its steerage or the way it interprets elements of the regulation, similar to what number of instances it meets with drugmakers, or what number of listening periods it holds. “The diploma to which they play hardball with producers within the course of might change,” she stated.